Since its inception in 1992, Eurofins bioskin has been recognized as a valuable partner for clinical trials in dermatological indications. Starting as a small Contract Research Organization (CRO) specialized in conducting early phase safety and efficacy trials, bioskin has grown into a full-service CRO offering global dermatologic consulting and regulatory services and all services for management of Phase I-IV drug trials and medical device studies. Eurofins bioskin is headquartered in Hamburg, Germany.

 We are unique in our understanding and capabilities for both early and late phase development of dermatological and related products. A core expertise is the development of innovative test designs, interpretation of study results, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. For global early and late phase studies bioskin partners with selected, reliable partners throughout Europe, US, Latin America, Central & Eastern Europe and South Africa.